I have to admit that I had lost faith in Management's ability to take the App through to commercialisation mainly due to my perception that the medical fraternity would not allow the device to impinge on their God given right to be the sole arbiter of respiratory diagnosis. This announcement appears to knock that perception on the head as doctors now see ResAppDx-Eu as being "invaluable" in helping them make differential diagnoses of respiratory disease. If there has been one good thing to come out of COVID-19, then this is it. I am now once again a "true believer".
- Forums
- ASX - By Stock
- RAP
- Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic
Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic, page-63
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online